MA vs WFC: Which Is the Better Buy?

Side-by-side comparison of Mastercard Incorporated and Wells Fargo & Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Mastercard Incorporated Β· Financial Services
$574.42
+25.0% upside to fair value
Med Conviction Grade A- High Quality
VS
Wells Fargo & Company Β· Financial Services
$86.12
+20.4% upside to fair value
Med Conviction Grade B
QuantHub Verdict
MA has more upside to fair value (+25.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MA WFC
Current Price $574.42 $86.12
Fair Value Estimate $718.00 $103.68
Upside to Fair Value +25.0% +20.4%
Market Cap $503.8B $260.4B
Forward P/E β€” β€”
EV / EBITDA 23.4x 15.6x
Price / Sales 14.4x 2.0x
Price / FCF 30.8x 13.7x
Revenue Growth YoY +14.1% +11.3%
Gross Margin 100% 64.5%
Operating Margin 59.8% 21.2%
Return on Equity 232.5% 12.6%
Dividend Yield 0.59% 2.15%
FCF Yield 3.25% 7.3%
Analyst Consensus Strong Buy Hold
Investment Thesis
MA β€” Mastercard Incorporated
Mastercard operates a global payments network that connects issuers, acquirers, merchants and consumers across more than 200 countries and territories, monetizing payment volumes, cross-border activity and higher-growth value-added services. Business quality is high because its two-sided network, trusted authorization-clearing-settlement infrastructure, brand, security capabilities and broad acce…
WFC β€” Wells Fargo & Company
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
Metric MA WFC
Zone Low $538.50 $77.76
Zone High $610.30 $88.13
In Buy Zone? Yes Yes
← MA Research    WFC Research β†’    All Research